2-Buten-1-one, 1-(2,2,6-trimethylcyclohexyl)-
Common Name: |
2-Buten-1-one, 1-(2,2,6-trimethylcyclohexyl)- |
IUPAC Name: |
1-(2,2,6-trimethylcyclohexyl)but-2-en-1-one |
Molecular Formula: |
C13H22O |
SMILES: |
CC=CC(=O)C1C(CCCC1(C)C)C |
Inchi: |
1S/C13H22O/c1-5-7-11(14)12-10(2)8-6-9-13(12,3)4/h5,7,10,12H,6,8-9H2,1-4H3 |
Inchi Key: |
DDDIVAXBYDCLRR-UHFFFAOYSA-N |
Cas No: |
39900-18-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
194.31 |
Mass (g/mol) |
194.167 |
Molar Refractivity |
61.96 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
265.00 to 266.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.009 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.77 |
LogP |
3.594 |
iLOGP |
2.83 |
XLOGP3 |
4.12 |
WLOGP |
3.59 |
MLOGP |
3.04 |
ESOL Log S |
-3.51 |
ESOL Solubility (mg/ml) |
0.06 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.18 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-2.67 |
Silicos-IT Solubility (mg/ml) |
0.42 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.56 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.097 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.697 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |